Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154665 | SCV000204342 | likely benign | not specified | 2015-10-30 | criteria provided, single submitter | clinical testing | c.*8T>C in the 3' UTR of MYH6: This variant is not expected to have clinical si gnificance because it has been identified in 0.5% (53/10406) of African chromoso mes by the Exome Aggregation Constortium (ExAC, http://exac.broadinstitute.org; dbSNP rs201560522). |
Gene |
RCV000154665 | SCV000513794 | benign | not specified | 2016-11-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154665 | SCV000919831 | benign | not specified | 2017-10-23 | criteria provided, single submitter | clinical testing | Variant summary: The MYH6 c.*8T>C variant involves the alteration of a non-conserved nucleotide in the 3' UTR. This variant was found in 109/277228 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.004411 (106/24030). This frequency is about 176 times the estimated maximal expected allele frequency of a pathogenic MYH6 variant (0.000025), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories classified this variant as likely benign/benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Taken together, this variant is classified as benign. |